2020
DOI: 10.3390/pathogens9030226
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Diagnostic Approaches for Epstein–Barr Virus

Abstract: my (M.A.H.A.); irekeola@student.usm.my (A.A.I.); hanimkk@usm.my (R.H.S.)Abstract: Epstein-Barr virus (EBV) is the causative agent of many diseases including infectious mononucleosis (IM), and it is associated with different subtypes of lymphoma, sarcoma and carcinoma such as Hodgkin's lymphoma, non-Hodgkin's lymphoma, nasopharyngeal carcinoma, and gastric carcinoma. With the advent of improved laboratory tests for EBV, a timelier and accurate diagnosis could be made to aid better prognosis and effective treatm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
71
0
5

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 76 publications
(76 citation statements)
references
References 72 publications
0
71
0
5
Order By: Relevance
“…Virus latency (past infection) is evidenced by the detection of specific IgG to nuclear antigens, typically EBNA-1. EBV reactivation can be evidenced directly by the detection of virus DNA using quantitative EBV viral load assays [26]; however, a limitation of viral load assays is their variability and lack of specificity in differentiating EBV reactivation from periodic virus shedding and for this reason they were not used in our study. In our study, no PwMS seroconverted to EBV VCA IgM or were EBV EA IgG seropositive during the study period.…”
Section: Discussionmentioning
confidence: 99%
“…Virus latency (past infection) is evidenced by the detection of specific IgG to nuclear antigens, typically EBNA-1. EBV reactivation can be evidenced directly by the detection of virus DNA using quantitative EBV viral load assays [26]; however, a limitation of viral load assays is their variability and lack of specificity in differentiating EBV reactivation from periodic virus shedding and for this reason they were not used in our study. In our study, no PwMS seroconverted to EBV VCA IgM or were EBV EA IgG seropositive during the study period.…”
Section: Discussionmentioning
confidence: 99%
“…The symptoms are fever, pharyngeal pain, fatigue and lymphadenectasis. A few patients have swelling in tonsils, spleen and liver [6,7]. "Abnormal lymphocytes" can be found in peripheral blood, they are usually identi ed as CD8-positive T cells [8].…”
Section: Discussionmentioning
confidence: 99%
“…At least one protein derived from plasma EVs, claudin-4, may be useful for diagnosis [ 132 ]. Serum-derived EVs from patients with nasopharyngeal carcinoma, a malignancy associated with Epstein-Barr virus (EBV) infection, have been shown to contain EBV components, including latent membrane protein-1 (LMP-1), BamHI-A rightward frame 1 (BARF1), and nucleic acids [ 133 ]. Such EV-derived proteins may serve as a more accurate alternative for diagnosis compared with anti-IgA/IgG and anti-VCA tests [ 134 ].…”
Section: Diagnosis Of Disease Based On Analysis Of Evs In Liquid Bmentioning
confidence: 99%